Literature DB >> 2888599

Drug-induced left ventricular failure in patients with pulmonary disease. Endomyocardial biopsy demonstration of catecholamine myocarditis.

A F Nino1, M M Berman, E H Gluck, M M Conway, J P Fisher, J E Dougherty, M A Rossi.   

Abstract

Three patients with severe chronic lung disease had left ventricular failure develop with marked impairment of cardiac function. Ejection fractions by radioactive blood pool ventriculography were 0.17, 0.24, and 0.20. Right ventricular endomyocardial biopsy specimens showed interstitial hemorrhage and foci of interstitial polymorphonuclear leukocytes, strongly suggestive of catecholamine myocarditis. These patients had used beta-adrenergic agonist inhalants and methylxanthines. One of them clearly abused the inhalant and had elevated levels of urinary catecholamines. Progressive deterioration of pulmonary and cardiac function occurred in two patients, with death within three months of the initial myocardial biopsy. Concomitant use of beta-adrenergic agonists and methylxanthines may cause myocarditis with left ventricular failure in susceptible patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888599     DOI: 10.1378/chest.92.4.732

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.

Authors:  E M Gilbert; J B O'Connell; M R Bristow
Journal:  Heart Vessels Suppl       Date:  1991

Review 2.  Strategies in managing asthma.

Authors:  A F Barker
Journal:  West J Med       Date:  1989-03

3.  Creatine kinase activity in patients with brittle asthma treated with long term subcutaneous terbutaline.

Authors:  A P Sykes; N Lawson; J A Finnegan; J G Ayres
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

4.  Acute hemorrhagic myocarditis in systemic lupus erythematosus.

Authors:  P Dickens; J Nicholls; C P Lau
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.